Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family study

Abstract

The endothelins are among the most potent vasoconstrictors known. Pharmacological inhibition of endothelin receptors lowers blood pressure (BP). It is unknown whether naturally occurring genetic variation in the endothelin receptors influences BP. We have evaluated the type A endothelin receptor (EDNRA) as a candidate gene for hypertension in a large family study. A total of 1425 members of 248 families selected via a proband with hypertension were studied. Ambulatory BP monitoring was conducted using the A&D TM2421 device. Four haplotype-tagging single nucleotide polymorphisms (SNPs) spanning the EDNRA gene were typed. There was evidence of association between genotype at the rs5335 (C+70G) SNP and night systolic blood pressure (+1.24% (s.e. 0.64) per G allele; P=0.05); night diastolic blood pressure (+1.64% (s.e. 0.71) per G allele; P=0.021) and night mean BP (+1.51% (s.e. 0.64) per G allele; P=0.017). Borderline significant trends in the same direction were seen for daytime BPs. Proportions of hypertensives in each of the three genotype groups were C/C 34.7%, C/G 37.9%, G/G 42.4% yielding an odds ratio for hypertension per G allele of 1.19 (95% confidence interval 1.00–1.41; P=0.05). In conclusion, the rs5335 (C+70G) polymorphism of the EDNRA gene has small effects on the risk of hypertension. Natural variation in other genes in the endothelin-signalling pathway should be explored to identify additional influences on BP regulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Ward RH . Genetic and sociocultural components of high blood pressure. Am J Phys Anthropol 1983; 62 (1): 91–105.

    Article  CAS  Google Scholar 

  2. Coats AJ, Radaelli A, Clark SJ, Conway J, Sleight P . The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 1992; 10 (4): 385–391.

    Article  CAS  Google Scholar 

  3. Conway J, Johnston J, Coats A, Somers V, Sleight P . The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 1988; 6 (2): 111–116.

    Article  CAS  Google Scholar 

  4. Cardon LR, Palmer LJ . Population stratification and spurious allelic association. Lancet 2003; 361 (9357): 598–604.

    Article  Google Scholar 

  5. Campbell CD, Ogburn EL, Lunetta KL, Lyon HN, Freedman ML, Groop LC et al. Demonstrating stratification in a European American population. Nat Genet 2005; 37 (8): 868–872.

    Article  CAS  Google Scholar 

  6. Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 2004; 36 (4): 388–393.

    Article  CAS  Google Scholar 

  7. Spieker LE, Noll G, Ruschitzka FT, Luscher TF . Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future? J Am Coll Cardiol 2001; 37 (6): 1493–1505.

    Article  CAS  Google Scholar 

  8. Serneri GGN, Cecioni I, Vanni S, Paniccia R, Bandinelli B, Vetere A et al. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ Res 2000; 86 (4): 377–385.

    Article  CAS  Google Scholar 

  9. Vickers MA, Green FR, Terry C, Mayosi BM, Julier C, Lathrop M et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002; 53 (4): 1029–1034.

    Article  CAS  Google Scholar 

  10. Keavney B, Bird R, Caiazza A, Casadei B, Conway J . Measurement of blood pressure using the auscultatory and oscillometric methods in the same cuff deflation: validation and field trial of the A&D TM2421 monitor. J Hum Hypertens 2000; 14 (9): 573–579.

    Article  CAS  Google Scholar 

  11. Wigginton JE, Abecasis GR . PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 2005; 21 (16): 3445–3447.

    Article  CAS  Google Scholar 

  12. Abecasis GR, Cherny SS, Cookson WO, Cardon LR . Merlin—rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30 (1): 97–101.

    Article  CAS  Google Scholar 

  13. Phillips MS, Lawrence R, Sachidanandam R, Morris AP, Balding DJ, Donaldson MA et al. Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat Genet 2003; 33 (3): 382–387.

    Article  CAS  Google Scholar 

  14. Tobin MD, Sheehan NA, Scurrah KJ, Burton PR . Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure. Stat Med 2005; 24 (19): 2911–2935.

    Article  Google Scholar 

  15. Abecasis GR, Cardon LR, Cookson WO . A general test of association for quantitative traits in nuclear families. Am J Hum Genet 2000; 66 (1): 279–292.

    Article  CAS  Google Scholar 

  16. Stevens P, Brown MJ . Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995; 26 (3): S9–S12.

    Article  CAS  Google Scholar 

  17. Benjafield AV, Katyk K, Morris BJ . Association of EDNRA, but not WNK4 or FKBP1B, polymorphisms with essential hypertension. Clin Genet 2003; 64 (5): 433–438.

    Article  CAS  Google Scholar 

  18. Ormezzano O, Poirier O, Mallion JM, Nicaud V, Amar J, Chamontin B et al. A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens 2005; 23 (11): 2019–2026.

    Article  CAS  Google Scholar 

  19. Iemitsu M, Maeda S, Otsuki T, Sugawara J, Tanabe T, Jesmin S et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects. Hypertension 2006; 47 (5): 928–936.

    Article  CAS  Google Scholar 

  20. Nicaud V, Poirier O, Behague I, Herrmann S-M, Mallet C, Troesch A et al. Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: The etude cas-temoins sur l'infarctus du myocarde (ECTIM) study. Am J Hypertens 1999; 12 (3): 304–310.

    Article  CAS  Google Scholar 

  21. Hasegawa KFH, Doyama K, Inada T, Ohtani S, Fujiwara T, Hosoda K et al. Endothelin-1-selective receptor in the arterial intima of patients with hypertension. Hypertension 1994; 3: 288–293.

    Article  Google Scholar 

  22. Campia U, Cardillo C, Panza JA . Ethnic differences in the vasoconstrictor activity of endogenous endothelin-1 in hypertensive patients. Circulation 2004; 109 (25): 3191–3195.

    Article  Google Scholar 

  23. Brown LA, Nunez DJ, Brookes CI, Wilkins MR . Selective increase in endothelon-1 and endothelin A receptor subtype in the hypertrophied myocardium of the aorto-venacaval fistula rat. Cardiovasc Res 1995; 29: 768–774.

    Article  CAS  Google Scholar 

  24. Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, Granger JP . Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension 1998; 31: 397–402.

    Article  CAS  Google Scholar 

  25. Alexander BT, Rinewalt AN, Cockrell KL, Massey MB, Bennett WA, Granger JP . Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37: 485–489.

    Article  CAS  Google Scholar 

  26. Allcock GH, Venema RC, Pollock DM . ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats. Am J Physiol Regul Integr Comp Physiol 1998; 275 (1): R245–R252.

    Article  CAS  Google Scholar 

  27. Bird JE, Moreland S, Waldron TL, Powell JR . Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension 1995; 25 (6): 1191–1195.

    Article  CAS  Google Scholar 

  28. Reinhart GA, Preusser LC, Opgenorth TJ, Wegner CD, Cox BF . Endothelin and ETA receptors in long-term arterial pressure homeostasis in conscious nonhuman primates. Am J Physiol Regul Integr Comp Physiol 2000; 279 (5): R1701–R1706.

    Article  CAS  Google Scholar 

  29. Nakov R, Pfarr E, Eberle S, HEAT Investigators. An effective endothelin A receptor antagonist for treatment of hypertension. Am J Hypertens 2002; 15: 583–589.

    Article  CAS  Google Scholar 

  30. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon III RO, Panza JA . Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33 (2): 753–758.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The genotyping of EDNRA was funded by the British Heart Foundation. The family collection was funded in 1993–96 by the Wellcome Trust.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B Keavney.

Additional information

No part of this work has been previously published or presented.

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rahman, T., Baker, M., Hall, D. et al. Common genetic variation in the type A endothelin-1 receptor is associated with ambulatory blood pressure: a family study. J Hum Hypertens 22, 282–288 (2008). https://doi.org/10.1038/sj.jhh.1002322

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002322

Keywords

This article is cited by

Search

Quick links